Featured in Pfizer
What to consider when taking Pfizer’s COVID-19 pill Paxlovid
The drug can interact with many other medications but is still extremely effective in preventing severe COVID-19.
mRNA COVID vaccines pose no serious risks for immunocompromised people
Data from an Italian study on high-risk volunteers boosts confidence in the safety of the Pfizer and Moderna shots.
The FDA just announced new booster guidelines for kids ages 12 to 15
It also changed the wait for a Pfizer booster to five months, not six.
The FDA just authorized the first pills for treating COVID-19
But that doesn't mean Paxlovid is coming to a pharmacy near you.
Some people have a gene that could make COVID far more deadly
Kids are getting COVID-19 pricks, people are getting out their passports, and vaccination requirements are working.
How dangerous is myocarditis? The truth about the scary-sounding condition.
Despite the attention on myocarditis, inflammation from mRNA vaccines is rare, and goes away in a matter of days.
Mixing and matching COVID-19 vaccines could provide superior immunity
The approach could prompt a powerful immune response.
FDA expert panel recommends all J&J vaccine recipients get a booster
The one-shot vaccine might have always been meant to be a two-dose regimen.
Mixing boosters, tuberculosis rising, and other COVID news you missed this week
Here's everything you need to know this week.
Everything you need to know about COVID booster shots
Whether boosters will be needed for the general population isn’t yet known.